Insulin-like growth factor binding proteins: Do they play a role in polycystic ovary syndrome?

Seminars in Reproductive Endocrinology

Volumn 15, Issue 2, 1997, Pages 123-136

  Cataldo, Nicholas A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

insulin like growth factor binding proteins; insulin like growth factors; Polycystic ovary syndrome

Indexed keywords

BINDING PROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ANIMAL CELL; ANOVULATION; ARTICLE; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; HYPERANDROGENISM; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RAT; THECA CELL;

EID: 0030950041     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016295     Document Type: Article

References (143)

1. Sakano K, Enjoh T, Numata F, Fujiwara H, Marumoto Y, Higashihashi N, Sato Y, Perdue JF, Fujita-Yamaguchi Y: The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor. J Biol Chem 266:20626-20635, 1991
2. Oh Y, Muller HL, Lee DY, Fielder PJ, Rosenfeld RG: Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Endocrinology 132:1337-1344, 1993
3. Rechler MM: Insulin-like growth factor binding proteins. Vitam Horm 47:1-114, 1993
4. Shimasaki S, Ling N: Identification and characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Progr Growth Factor Res 3:243-266, 1991
5. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34, 1995
6. Oh Y, Muller HL, Lamson G, Rosenfeld RG: Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 268:14964-14971, 1993
7. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M: Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143, 1986
8. Honda Y, Landale EC, Strong DD, Baylink DJ, Mohan S: Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids. J Clin Endocrinol Metab 81:1389-1396, 1996
9. Mohan S, Libanati C, Dony C, Lang K, Srinivasan N, Baylink DJ: Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab 80:2638-2645, 1995
10. Baxter RC, Saunders H: Radioimmunoassay of insulin-like like growth factor-binding protein-6 in human serum and other body fluids. J Endocrinol 134:133-139, 1992
11. Lee PDK, Conover CA, Powell DR: Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exper Biol Med 204:4-29, 1993
12. Baxter RC: Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 42:140-144, 1994
13. Bergh C, Hillensjö T, Wikland M, Nilsson L, Borg G, Hamberger L: Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertil Steril 62:113-120, 1994
14. Van Dessel HJHMT, Chandrasekher Y, Yap OWS, Lee PDK, Hintz RL, Faessen GHJ, Braat DDM, Fauser BCJM, Giudice LC: Serum and follicular fluid levels of insulin-like growth factor 1 (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. J Clin Endocrinol Metab 81:1224-1231, 1996
15. Martikainen HJ, Tapanainen J, Rönnberg L, Kauppila A, Selenius P, Seppälä M: Insulin-like growth factor binding protein-1 and ovarian stimulation. Human Reprod 6: 1220-1222, 1991
16. El-Roeiy A, Chen X, Roberts VJ, Shimasaki S, Ling N, LeRoith D, Roberts, Jr. CT, Yen SSC: Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 78:1488-1496, 1994
17. Zapf J, Schmid CH, Guler HP, Waldvogel M, Hauri CH, Futo E, Hossenlopp P, Binoux M, Froesch ER: Regulation of binding proteins for insulin-like growth factors in humans: increased expression of IGF binding protein 2 during IGF-I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest 86: 952-961, 1990
18. Baxter RC, Martin JL: Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78:1504-1512, 1986
19. Baxter RC: Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab 70:1347-1353, 1990
20. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, Lafranchi S, Lippe B, Loriaux L, Melmed S, Preece MA, Ranke MB, Reiter EO, Rogol AD, Underwood LE, Werther GA: Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 80:1532-1540, 1995
21. Gargosky SE, Pham HM, Wilson KF, Liu F, Giudice LC, Rosenfeld RG: Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: Discrepancies between radioimmunoassay and ligand blotting. Endocrinology 131:3051-3060, 1992
22. Hernandez ER, Hurwitz A, Vera A, Pellicer A, Adashi EY, LeRoith D, Roberts, Jr. CT: Expression of the genes encoding the insulin-like growth factors and their receptor in the human ovary. J Clin Endocrinol Metab 74:419-425, 1992
23. Giudice LC: Insulin-like growth factors and ovarian follicular development. Endocrine Rev 13:641-669, 1992
24. El-Roeiy A, Chen X, Roberts VJ, LeRoith D, Roberts, Jr. CT, Yen SSC: Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. J Clin Endocrinol Metab 77:1411-1418, 1993
25. Mason HD, Cwyfan-Hughes SC, Heinrich G, Franks S, Holly JMP: Insulin-like growth factor (IGF) I ad II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries. J Clin Endocrinol Metab 81:276-284, 1996
26. Adashi EY: Growth factors and ovarian function: the IGF-I paradigm. Horm Res 42:44-48, 1994
27. Hammond JM, Samaras SE, Grimes R, Leighton J, Barber J, Canning SF, Guthrie HD: The role of insulin-like growth factors and epidermal growth factor-related peptides in intraovarian regulation in the pig ovary. J Reprod Fertil 48(Suppl.):117-125, 1993
28. Monget P, Monniaux D, Pisselet C, Durand P: Changes in insulin-like growth factor-I (IGF-I), IGF-II, and their binding proteins during growth and atresia of ovine ovarian follicles. Endocrinology 132:1438-1446, 1993
29. Sakal E, Gertler A, Aflalo L, Meidan R: Characterization of insulin-like growth factor binding proteins secreted by cultured bovine theca and granulosa cells. Mol Cell Endocrinol 90:39-46, 1992
30. Zhou J, Bondy C: Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod 48:467-482, 1993
31. Seppälä M, Wahlstrom T, Koskimies AI, Tenhunen A, Rutanen EM, Koistinen R, Huhtaniemi I, Bohn H, Stenman UH: Human preovulatory follicular fluid, luteinized cells of hyperstimulated preovulatory follicles, and corpus luteum contain placental protein 12. J Clin Endocrinol Metab 58:505-510, 1984
32. San Roman GA, Magoffin DA: Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. J Clin Endocrinol Metab 75:1010-1016, 1992
33. Woodruff TK, Battaglia J, Bowdidge A, Molskness TA, Stouffer RL, Cataldo NA, Giudice LC, Orly J, Mather JP: Comparison of functional response of rat, macaque, and human ovarian cells in hormonally defined medium. Biol Reprod 48:68-76, 1993
34. Chandrasekher YA, Clark CR, Faessen GH, Giudice LC: Role of insulin-like growth factor binding protein-4 (IGFBP-4) and IGFBP-4 protease in human granulosa cell function. Proceedings of the Society for the Study of Reproduction 28th Annual Meeting, Davis, CA, 1995, p 82
35. Suikkari A-M, Jalkanen J, Koistinen R, Bützow R, Ritvos O, Ranta T, Seppälä M: Human granulosa cells synthesize low molecular weight insulin-like growth factor-binding protein. Endocrinology 124:1088-1090, 1989
36. Koistinen R, Suikkari A-M, Tiitinen A, Kontula K, Seppälä M: Human granulosa cells contain insulin-like growth factor-binding protein (IGF BP-1) mRNA. Clin Endocrinol (Oxf) 32:635-640, 1990
37. Giudice LC, Milki AA, Milkowski DA, El Danasouri I: Human granulosa contain messenger ribonucleic acids encoding insulin-like growth factor-binding proteins (IGFBPs) and secrete IGFBPs in culture. Fertil Steril 56: 475-480, 1991
38. Cataldo NA, Woodruff TK, Giudice LC: Regulation of insulin-like growth factor binding protein production by human luteinizing granulosa cells cultured in defined medium. J Clin Endocrinol Metab 76:207-215, 1993
39. Cataldo NA, Jaffe RB: Interferon-gamma promotes insulin-like growth factor binding protein-2 (IGFBP-2) and IGFBP-4 production by human luteinizing granulosa cells: Possible role in apoptosis. International Symposium on the Life Cycle of the Ovarian Follicle, Serono Symposia USA, Fort Lauderdale, FL, 1995, p 35
40. Cataldo NA, Fujimoto VY, Jaffe RB: Activin-A stimulates the expression of insulin-like growth factor binding protein-5 messenger RNA in human luteinizing granulosa cells. Recent Progr Horm Res 50:437-442, 1995
41. Sarvas K, Angervo M, Koistinen R, Tiitinen A, Seppälä N: Prostaglandin F2-alpha stimulates release of insulin-like growth factor binding protein-3 from cultured human granulosa-luteal cells. Human Reprod 9:1643-1646, 1994
42. Chandrasekher YA, Van Dessel HJHM, Fauser BCJM, Giudice LC: Estrogen- but not androgen-dominant human ovarian follicular fluid contains an insulin-like growth factor binding protein-4 protease. J Clin Endocrinol Metab 80:2734-2739, 1995
43. Cwyfan-Hughes SC, Mason HK, Franks S, Holly JMP: Proteolytic modification of IGFBPs in human follicular fluid during follicle maturation. Tenth International Congress of Endocrinology, San Francisco, CA, 1996, p 783
44. Liu XJ, Malkowski M, Guo Y, Erickson GF, Shimasaki S, Ling N: Development of specific antibodies to rat insulin- like growth factor-binding proteins (IGFBP-2 to -6): Analysis of IGFBP production by rat granulosa cells. Endocrinology 132:1176-1183, 1993
45. Fielder PJ, Pham H, Adashi EY, Rosenfeld RG: Insulin-like growth factors (IGFs) block FSH-induced proteolysis of IGF-binding protein-5 (BP-5) in cultured rat granulosa cells. Endocrinology 133:415-418, 1993
46. Jalkanen J, Suikkari A-M, Koistinen R, Bützow R, Ritvos O, Seppälä M, Ranta T: Regulation of insulin-like growth factor-binding protein-1 production in human granulosaluteal cells. J Clin Endocrinol Metab 69:1174-1179, 1989
47. Dor J, Costritsci N, Pariente C, Rabinovici J, Mashiach SS, Lunenfeld B, Kaneti H, Seppälä M, Koistinen R, Karasik A: Insulin-like growth factor-I and follicle-stimulating hormone suppress insulin-like growth factor binding protein-1 secretion by human granulosa-luteal cells. J Clin Endocrinol Metab 75:969-971, 1992
48. Angervo M, Koistinen M, Seppälä M: Epidermal growth factor stimulates production of insulin-like growth factor-binding protein-1 in human granulosa-luteal cells. J Endocrinol 134:127-131, 1992
49. Adachi T, Iwashita M, Kuroshima A, Takeda Y: Regulation of IGF binding proteins by FSH in human luteinizing granulosa cells. J Assist Reprod Genet 12:639-643, 1995
50. Poretsky L, Chandrasekher YA, Bai C, Liu HC, Rosenwaks Z, Giudice LC: Insulin receptor mediates inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-I, on IGF binding protein 1 (IGFBP-1) production in human granulosa cells. J Clin Endocrinol Metab 81:493-496, 1996
51. Cataldo N A, Fujimoto VY, Jaffe RB: Activin-A stimulates the production of insulin-like growth factor binding proteins by human luteinizing granulosa cells. Proceedings of the Society for Gynecologic Investigation 41st Annual Meeting, Chicago, IL, 1994, p 113
52. Hamori M, Blum WF, Török A, Stehle R, Waibel E, Cledon P, Ranke MB: Immunoreactive insulin-like growth factor binding protein-3 in the culture of human luteinized granulosa cells. Acta Endocrinologica 124:685-691, 1991
53. Nakatani A, Shimasaki S, Erickson GF, Ling N: Tissue-specific expression of four insulin-like growth factor-binding proteins (1, 2, 3, and 4) in the rat ovary. Endocrinology 129:1521-1529, 1991
54. Erickson GF, Nakatani A, Ling N, Shimasaki S: Localization of insulin-like growth factor-binding protein-5 messenger ribonucleic acid in rat ovaries during the estrous cycle. Endocrinology 130:1867-1878, 1992
55. Chandrasekher YA, Clark CR, Faessen GH, Giudice LC: Insulin-like growth factor binding protein profile in theca explant cultures from normal human ovaries. Proceedings of The Endocrine Society 77th Annual Meeting, Washington, DC, 1995, p 166
56. Giudice LC, Farrell EM, Pham H, Rosenfeld RG: Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) and IGFBP-2 in human follicular fluid. J Clin Endocrinol Metab 71:1330-1338, 1990
57. Huang ZH, Matson P, Lieberman BA, Morris ID: Insulin-like growth factor binding proteins in serum and follicular fluid from women undergoing ovarian stimulation with and without growth hormone. Human Reprod 9:1421-1426, 1994
58. Hartshorne GM, Bell SC, Waites GT: Binding proteins for insulin-like growth factors in the human ovary: Identification, follicular fluid levels and immunohistochemical localization of the 29-32 kd type 1 binding protein, IGF-bpl. Human Reprod 5:649-660, 1990
59. Hamori M, Blum WF, Török A, Stehle R, Waibel E, Cledon P, Ranke MB: Insulin-like growth factors and their binding proteins in human follicular fluid. Human Reprod 6:313-318, 1991
60. Chang SY, Hsieh K-C, Wang H-S, Soong Y-K: Follicular fluid levels of insulin-like growth factor I, insulin-like growth factor binding protein I, and ovarian steroids collected during ovum pick-up. Fertil Steril 62:1162-1167, 1994
61. Huang ZH, Baxter RC, Hughes SM, Matson PL, Liberman BA, Morris ID: Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotropins: Changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3). Human Reprod 8:850-857, 1993
62. McNatty KP, Smith DM, Makris A, Osathanondh R, Ryan KJ: The micro-environment of the human antral follicle: Interrelationships among the steroid level in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 49: 851-860, 1979
63. Brailly S, Gougeon A, Milgrom E, Bomsel-Helmreich O, Papiernik E: Androgens and progestins in the human ovarian follicle: Differences in the evolution of preovulatory, healthy nonovulatory, and atretic follicles. J Clin Endocrinol Metab 53:128-134, 1981
64. Cataldo NA, Giudice LC: Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status. J Clin Endocrinol Metab 74:821-829, 1992
65. San Roman GA, Magoffin DA: Insulin-like growth factor-binding proteins in healthy and atretic follicles during natural menstrual cycles. J Clin Endocrinol Metab 76: 625-632, 1993
66. Schuller AGP, Lindenbergh-Kortleve DJ, Pache TD, Zwarthoff EC, Fauser BCJM, Drop SLS: Insulin-like growth factor binding protein-2, 28 kDa and 24 kDa insulin-like growth factor binding protein levels are decreased in fluid of dominant follicles, obtained from normal and polycystic ovaries. Regul Peptides 48:157-163, 1993
67. Holly JMP, Eden JA, Alaghband-Zadeh J, Carter GD, Jemmott RC, Cianfarani S, Chard T, Wass JAH: Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polycystic and multicystic ovaries. Clin Endocrinol (Oxf) 33:53-64, 1990
68. Erickson GF, Garzo VG, Magoffin DA: Insulin-like growth factor-1 regulates aromatase activity in human granulosa and granulosa-luteal cells. J Clin Endocrinol Metab 69:716-724, 1989
69. Bergh C, Olsson JH, Hillensjo T: Effect of insulin-like growth factor I on steroidogenesis in cultured human granulosa cells. Acta Endocrinologica 125:177-185, 1991
70. Christman GM, Randolph, Jr. JF, Peegel H, Menon KMJ: Differential responsiveness of luteinized human granulosa cells to gonadotropins and insulin-like growth factor I for induction of aromatase activity. Fertil Steril 55: 1099-1105, 1991
71. Olsson JH, Carlsson B, Hillensjö T: Effect of insulin-like growth factor I on deoxyribonucleic acid synthesis in cultured human granulosa cells. Fertil Steril 54:1052-1057, 1990
72. Erickson GF, Garzo VG, Magoffin DA: Progesterone production by human granulosa cells cultured in serum free medium: Effects of gonadotropins and insulin-like growth factor-I (IGF-I). Human Reprod 6:1074-1081, 1991
73. Angervo M, Koistinen R, Suikkari A-M, Seppälä M: Insulin-like growth factor binding protein-1 inhibits the DNA amplification induced by insulin-like growth factor I in human granulosa-luteal cells. Human Reprod 6:770-773, 1991
74. Yong EL, Baird DT, Yates R, Reichert, Jr. LE, Hillier SG: Hormonal regulation of the growth and steroidogenic function of human granulosa cells. J Clin Endocrinol Metab 74:842-849, 1992
75. Mason HD, Willis DS, Holly JMP, Franks S: Insulin preincubation enhances insulin-like growth factor-II (IGF-II) action on steroidogenesis in human granulosa cells. J Clin Endocrinol Metab 78:1265-1267, 1994
76. DiBlasio AM, Viganò P, Ferrari A: Insulin-like growth factor-II stimulates human granulosa-luteal cell proliferation in vitro. Fertil Steril 61:483-487, 1994
77. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ: Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J Clin Endocrinol Metab 72:1206-1211, 1991
78. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ: Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Molec Cell Endocrinol 75:R1-R6, 1991
79. Bergh C, Carlsson B, Olsson JH, Selleskog U, Hillensjö T: Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril 59:323-331, 1993
80. Nahum R, Thong KJ, Millier SG: Metabolic regulation of androgen production by human thecal cells in vitro. Human Reproduction 10:75-81, 1995
81. Ui M, Shimonaka M, Shimasaki S, Ling N: An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells. Endocrinology 125:912-916, 1989
82. Bicsak TA, Shimonaka M, Malkowski M, Ling N: Insulin-like growth factor-binding protein (IGF-BP) inhibition of granulosa cell function: effect on cyclic adenosine 3′,5′-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF antibody. Endocrinology 126:2184-2189, 1990
83. Adashi EY, Resnick CE, Ricciarelli E, Hurwitz A, Hernandez ER: Insulin-like growth factor (IGF) binding protein-1 is an antigonadotropin: Evidence that optimal FSH action is contingent upon amplification by endogenously-derived IGFs. Society for Gynecologic Investigation 38th Annual Meeting, 1991, p 313
84. Adashi EY, Resnick CE, Ricciarelli E, Hurwitz A, Kokia E, Tedeschi C, Botero L, Hernandez ER, Rosenfeld RG, Carlsson-Skwirut C, Francis GL: Granulosa cell-derived insulin-like growth factor (IGF) binding proteins are inhibitory to IGF-I hormonal action: Evidence derived from the use of a truncated IGF-I analogue. J Clin Invest 90:1593-1599, 1992
85. Rohan RM, Ricciarelli E, Kiefer MC, Resnick CE, Adashi EY: Rat ovarian insulin-like growth factor-binding protein-6: A hormonally regulated theca-interstitial-selective species with limited antigonadotropic activity. Endocrinology 132:2507-2512, 1993
86. Bicsak TA, Ling N, DePaolo LV: Ovarian intrabursal administration of insulin-like growth factor-binding protein inhibits follicular rupture in gonadotropin-treated immature female rats. Biol Reprod 44:599-603, 1991
87. Chun S-Y, Billig H, Tilly JL, Furuta I, Tsafriri A, Hsueh AJW: Gonadotropin suppression of apoptosis in cultured preovulatory follicles: Mediatory role of endogenous insulin-like growth factor I. Endocrinology 135:1845-1853, 1994
88. Eisenhauer KM, Chun S-Y, Billig H, Hsueh AJW: Growth hormone suppression of apoptosis in preovulatory rat follicles and partial neutralization by insulin-like growth factor binding protein. Biol Reprod 53:13-20, 1995
89. Iwashita M, Adachi T, Katayama E, Kudo Y, Takeda Y: Regulation and physiological role of insulin-like growth factor binding protein-1 in human granulosa cells. Horm Res 41(Suppl. l):22-28, 1994
90. Mason HD, Willis D, Holly JMP, Cwyfan-Hughes SC, Seppälä M, Franks S: Inhibitory effects of insulin-like growth factor-binding proteins on steroidogenesis by human granulosa cells in culture. Molec Cell Endocrinol 89:R1-R4, 1992
91. Stein IF, Leventhal ML: Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181-191, 1935
92. Polson DW, Adams J, Wadsworth J, Franks S: Polycystic ovaries - A common finding in normal women. Lancet 1:870-872, 1988
93. Lobo RA: A disorder without identity: "HCA," "PCO," "PCOD," "SLS." What are we to call it?! Fertil Steril 63:1158-1160, 1995
94. Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174, 1989
95. Barbieri RL: Hyperandrogenism, insulin resistance and acanthosis nigricans: Ten years of progress. J Reprod Med 39:327-336, 1994
96. Talbot JA, Bicknell EJ, Rajkhowa M, Krook A, O'Rahilly S, Clayton RN: Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 81:1979-1983, 1996
97. Lee J, Pilch PF: The insulin receptor: Structure, function, and signaling. Am J Physiol 266:C319-C334, 1994
98. Dunaif A, Xia J, Book C-B, Schenker E, Tang Z: Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96:801-810, 1995
99. Willis D, Mason H, Gilling-Smith C, Franks S: Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81:302-309, 1996
100. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ: Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 62: 904-910, 1986
101. Gilling-Smith C, Willis DS, Mason HD, Franks S: Effects of insulin and insulin-like growth factors on androstenedione production by human theca cells. J Endocrinol 139(Suppl. 2):(abstract) O35, 1993
102. Poretsky L: On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 12:3-13, 1991
103. Kazer RR, Unterman TG, Click RP: An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 71:958-962, 1990
104. Nobels F, Dewailly D: Puberty and polycystic ovary syndrome: The insulin/insulin-like growth factor I hypothesis. Fertil Steril 58:655-666, 1992
105. Homburg R, Pariente C, Lunenfeld B, Jacobs HS: The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Human Reprod 7:1379-1383, 1992
106. Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SSC: Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: Common and distinct features. J Clin Endocrinol Metab 81:2854-2864, 1996
107. Erickson GF, Magoffin DA, Garzo VG, Cheung AP, Chang RJ: Granulosa cells of polycystic ovaries: Are they normal or abnormal? Hum Reprod 7:293-299, 1992
108. Mason HD, Willis DS, Beard RW, Winston RML, Margara R, Franks S: Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab 79:1355-1360, 1994
109. Erickson GF, Yen SSC: New data on follicle cells in polycystic ovaries: A proposed mechanism for the genesis of cystic follicles. Semin Reprod Endocrinol 2:231-243, 1984
110. Meirow D, Laufer N, Schenker JG: Ovulation induction in polycystic ovary syndrome: A review of conservative and new treatment modalities. Eur J Obstet Gynecol Reprod Biol 50:123-131, 1993
111. Trounson A, Wood C, Kausche A: In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril 62:353-362, 1994
112. Judd HL, Rigg LA, Anderson DC, Yen SS: The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 43:347-353, 1976
113. Greenblatt E, Casper RF: Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome. Am J Obstet Gynecol 156:279-285, 1987
114. Blankstein J, Rabinovici J, Goldenberg M, Shaley J, Mehta A, Serr DM, Mashiach S: Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease. J Clin Endocrinol Metab 65:1164-1167, 1987
115. Giudice LC, van Dessel HJHM, Cataldo NA, Chandrasekher YA, Yap OWS, Fauser BCJM: Circulating and ovarian IGF binding proteins: potential roles in normoovulatory cycles and in polycystic ovarian syndrome. Prog Growth Factor Res 6:397-408, 1995
116. Eden JA, Jones J, Carter GD, Alaghband-Zadeh J: A comparison of follicular fluid levels of insulin-like growth factor-I in normal dominant and cohort follicles, polycystic and multicystic ovaries. Clin Endocrinol (Oxf) 29:327-336, 1988
117. Eden JA, Jones J, Carter GD, Alaghband-Zadeh J: Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles. Clin Endocrinol (Oxf) 32:395-405, 1990
118. Erickson GF, Magoffin DA, Cragun JR, Chang RJ: The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab 70:894-902, 1990
119. Mason HD, Margara R, Winston RML, Seppala M, Koistinen R, Franks S: Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries. J Clin Endocrinol Metab 76:1275-1279, 1993
120. Andreani CL, Pierro E, Lanzone A, Lazzarin N, Capitanio G, Giannini P, Mancuso S: Effect of gonadotropins, insulin and IGF I on granulosa luteal cells from polycystic ovaries. Molec Cell Endocrinol 106:91-97, 1994
121. Gilling-Smith C, Willis DS, Beard RW, Franks S: Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 79:1158-1165, 1994
122. Cataldo NA, Giudice LC: Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome. J Clin Endocrinol Metab 74:695-697, 1992
123. Magoffin DA, San Roman GA, Muderspach LI: Insulin-like growth factor binding proteins in a natural pre-ovulatory follicle from a woman with polycystic ovary syndrome. Human Reprod 10:2248-2252, 1995
124. Schneyer AL, Sluss PM, Whitcomb RW, Martin KA, Sprengel R, Crowley, Jr. WF: Precursors of alpha-inhibition modulate follicle-stimulating hormone receptor binding and biological activity. Endocrinology 129:1987-1999, 1991
125. El-Roeiy A, Baxter RC, Chen X, Laughlin G, Yen SSC: The role of growth hormone (GH), insulin like growth factor (IGF I and IGF II) and their binding proteins (IGF BP3 and IGF BP1) in PCO syndrome. Proceedings of the Society for Gynecologic Investigation 38th Annual Meeting, San Antonio, TX, 1991, p 357
126. Morris RS, Carmina E, Vijod MA, Stanczyk FZ, Lobo RA: Alterations in the sensitivity of serum insulin-like growth factor 1 and insulin-like growth factor binding protein-3 to octreotide in polycystic ovary syndrome. Fertil Steril 63:742-746, 1995
127. van Dessel HJ, Aladin-Chandrasekher YA, Faessen G, Lee PD, Fauser BC, Giudice LC: Elevated serum levels of free insulin-like growth factor (IGF)-I in polycystic ovary syndrome. Proceedings of The American Society for Reproductive Medicine 52nd Annual Meeting, Boston, MA, 1996, p S193
128. Prelevic GM, Wurzburger MI, Balint-Perec L, Nesic J: Inhibitory effect of sandostatin on secretion of luteinizing hormone and ovarian steroids in polycystic ovary syndrome. Lancet 336:900-903, 1990
129. Fulghesu AM, Lanzone A, Andreani CL, Pierro E, Caruso A, Mancuso S: Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease. Fertil Steril 64:703-708, 1995
130. Prelevic GM, Ginsburg J, Maletic D, Hardiman P, Okolo S, Balint-Perec L, Thomas M, Orskov H: The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries. Hum Reprod 10:28-32, 1995
131. Gargosky SE, Wilson KF, Fielder PJ, Vaccarello MA, Cue- vara-Aguirre J, Diamond FB, Baxter RC, Rosenbloom AL, Rosenfeld RG: The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: Effects of IGF-I therapy on IGFBP-3. J Clin Endocrinol Metab 77:1683-1689, 1993
132. Suikkari A-M, Ruutiainen K, Erkkola R, Seppälä M: Low levels of low molecular weight insulin-like growth factorbinding protein in patients with polycystic ovarian disease. Hum Reprod 4:136-139, 1989
133. Pekonen F, Laatikainen T, Buyalos R, Rutanen E-M: Decreased 34K insulin-like growth factor binding protein in polycystic ovarian disease. Fertil Steril 51:972-975, 1989
134. Iwashita M, Mimuro T, Watanabe M, Setoyama T, Matsuo A, Adachi T, Takeda Y, Sakamoto S: Plasma levels of insulin-like growth factor-I and its binding protein in polycystic ovary syndrome. Horm Res 33(Suppl. 2):21-26, 1990
135. Conway GS, Jacobs HS, Holly JMP, Wass JAH: Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 33:593-603, 1990
136. Hamilton-Fairley D, Kiddy D, Anyaoku V, Koistinen R, Seppälä M, Franks S: Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction. Clin Endocrinol (Oxf) 39:363-367, 1993
137. Buyalos RP, Pekonen F, Halme JK, Judd HL, Rutanen EM: The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome. Amer J Obstet Gynecol 172:932-939, 1995
138. Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, Franks S: Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36:105-111, 1992
139. Holte J, Bergh T, Berne C, Wide L, Lithell H: Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 80:2586-2593, 1995
140. Kiddy DS, Hamilton-Fairley D, Seppälä M, Koistinen R, James VH, Reed MJ, Franks S: Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: Correlation with serum insulin and insulin-like growth factor-I. Clin Endocrinol (Oxf) 31:757-763, 1989
141. Tiitinen A, Tenhunen A, Seppälä M: Ovarian electrocauterization causes LH-regulated but not insulin-regulated endocrine changes. Clin Endocrinol (Oxf) 39:181-184, 1993
142. Greenblatt EM, Ben-Chetrit A, Steiner G, Lewis GF: Correction of hyperandrogenemia by laparoscopic ovarian cautery for polycystic ovary syndrome is not accompanied by improved insulin sensitivity or lipid concentrations. Tenth International Congress of Endocrinology, San Francisco, CA, 1996, p 562
143. Tiitinen AE, Laatikainen TJ, Seppälä MT: Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease. Fertil Steril 60:58-62, 1993